Afatinib is an orally bioavailable anilino-quinazoline derivative and inhibitor of the receptor tyrosine kinase (RTK) epidermal growth factor receptor (ErbB, EGFR) family, with antineoplastic activity.
Molecular Weight:
485.9
Purity:
>98%(HPLC)
CAS Number:
[439081-18-2]
Formula:
C24H25ClFN5O3
Target:
EGFR (L858R)| EGFR (L858R/T790M)| EGFR (wt)| HER2
* VAT and and shipping costs not included. Errors and price changes excepted